Coenzyme Q10 (CoQ10) is a fat-soluble, vitamin-like, benzoquinone compound that functions primarily as an antioxidant, as a membrane stabilizer and as a cofactor in the production of adenosine triphosphate (ATP) by oxidative phosphorylation. The solubility of CoQ10 in water is extremely low, resulting in a low bioavailability by oral administration. Therefore, we attempted to improve the low dissolution and bioavailability of CoQ10 by means of complexation with various cyclodextrins (CDs). We found that the bioavailability of CoQ10 could be significantly enhanced by complexation with CDs, especially by the use of γCD. The CoQ10 -γCD complex reveals excellent pharmacokinetic properties not only significantly higher area under the CoQ10 concentration curve (AUC) in blood plasma from time 0-48 hr and higher maximum plasma concentration (C max ), but also the mean plasma levels even after 24 and 48 hours tended to be significantly higher after CoQ10 -γCD complex administration to healthy adult volunteers when compared with CoQ10 formulated in microcrystalline cellulose and administrated in the same way as the complex. We found that this long-lasting high CoQ10 concentration in plasma provides various health benefits. The proven benefits are: 1) Curative effects on damaged human skins by aging, UV and other pollutants in the air, 2) Anti-oxidant activity (study on the reduction of 8-hydroxy-2-deoxy guanosine (8-OHdG) in urine), 3) Protection of muscle cells (study on the reduction of myogenic enzymes, creatinine phosphokinase (CPK) and lactate dehydrogenase (LDH)).